Ana Santos-Carvalho

Ana Santos-Carvalho

Auto-generated profile, based on publicly available information

Ana Santos-Carvalho

Rede SciComPt, Portugal

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 May 2013 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
ASA Santos-Carvalho
A Santos-Carvalho
FEF Elvas
F Elvas
AÁA R Álvaro
A R Álvaro
António Francisco AmbrósioAntónio Francisco Ambrósio
António Francisco Ambrósio
CCCláudia Cavadas
Cláudia Cavadas
It has been claimed that glutamate excitotoxicity might have a role in the pathogenesis of several retinal degenerative diseases, including glaucoma and diabetic retinopathy. Neuropeptide Y (NPY) has neuroprotective properties against excitotoxicity in the hippocampus, through the activation of Y1, Y2 and/or Y5 receptors. The principal objective of this study is to investigate the potential protective role of NPY against glutamate-induced toxicity in rat retinal cells (in vitro and in an animal model), unraveling the NPY receptors and intracellular mechanisms involved. Rat retinal neural cell cultures were prepared from newborn Wistar rats (P3-P5) and exposed to glutamate (500 μM) for 24 h. Necrotic cell death was evaluated by propidium iodide (PI) assay and apoptotic cell death using TUNEL and caspase-3 assays. The cell types present in culture were identified by immunocytochemistry. The involvement of NPY receptors was assessed using selective agonists and antagonists. Pre-treatment of cells with NPY (100 nM) inhibited both necrotic cell death (PI-positive cells) and apoptotic cell death (TUNEL-positive cells and caspase 3-positive cells) triggered by glutamate, with the neurons being the cells most strongly affected. The activation of NPY Y2, Y4 and Y5 receptors inhibited necrotic cell death, while apoptotic cell death was only prevented by the activation of NPY Y5 receptor. Moreover, NPY neuroprotective effect was mediated by the activation of PKA and p38K. In the animal model, NPY (2.35 nmol) was intravitreally injected 2 h before glutamate (500 nmol) injection into the vitreous. The protective role of NPY was assessed 24 h after glutamate (or saline) injection by TUNEL assay and Brn3a (marker of ganglion cells) immunohistochemistry. NPY inhibited the increase in the number of TUNEL-positive cells and the decrease in the number of Brn3a-positive cells induced by glutamate. In conclusion, NPY and NPY receptors can be considered potential targets to treat retinal degenerative diseases, such as glaucoma and diabetic retinopathy.

22 July 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
LSLígia Sousa-Ferreira
Lígia Sousa-Ferreira
MGManuel Garrido
Manuel Garrido
INIsabel Nascimento-Ferreira
Isabel Nascimento-Ferreira
CNClévio Nóbrega
Clévio Nóbrega
ASAna Santos-Carvalho
Ana Santos-Carvalho
CCCláudia Cavadas
Cláudia Cavadas
Neuropeptide Y (NPY) produced by arcuate nucleus (ARC) neurons has a strong orexigenic effect on target neurons. Hypothalamic NPY levels undergo wide-ranging oscillations during the circadian cycle and in response to fasting and peripheral hormones (from 0.25 to 10-fold change). The aim of the present study was to evaluate the impact of a moderate long-term modulation of NPY within the ARC neurons on food consumption, body weight gain and hypothalamic neuropeptides. We achieved a physiological overexpression (3.6-fold increase) and down-regulation (0.5-fold decrease) of NPY in the rat ARC by injection of AAV vectors expressing NPY and synthetic microRNA that target the NPY, respectively. Our work shows that a moderate overexpression of NPY was sufficient to induce diurnal over-feeding, sustained body weight gain and severe obesity in adult rats. Additionally, the circulating levels of leptin were elevated but the immunoreactivity (ir) of ARC neuropeptides was not in accordance (POMC-ir was unchanged and AGRP-ir increased), suggesting a disruption in the ability of ARC neurons to response to peripheral metabolic alterations. Furthermore, a dysfunction in adipocytes phenotype was observed in these obese rats. In addition, moderate down-regulation of NPY did not affect basal feeding or normal body weight gain but the response to food deprivation was compromised since fasting-induced hyperphagia was inhibited and fasting-induced decrease in locomotor activity was absent. These results highlight the importance of the physiological ARC NPY levels oscillations on feeding regulation, fasting response and body weight preservation, and are important for the design of therapeutic interventions for obesity that include the NPY.

1 July 2015 in Progress in Retinal and Eye Research
Verified
Journal Article
Closed access
ASAna Santos-Carvalho
Ana Santos-Carvalho
António Francisco AmbrósioAntónio Francisco Ambrósio
António Francisco Ambrósio
CCCláudia Cavadas
Cláudia Cavadas

1 January 2014 in Progress in Neurobiology
Verified
Journal Article
Closed access
ASAna Santos-Carvalho
Ana Santos-Carvalho
AÁAna Rita Álvaro
Ana Rita Álvaro
JMJoão Martins
João Martins
António Francisco AmbrósioAntónio Francisco Ambrósio
António Francisco Ambrósio
CCCláudia Cavadas
Cláudia Cavadas

1 January 2013 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Closed access
PDF file
ASAna Santos-Carvalho
Ana Santos-Carvalho
CACélia A. Aveleira
Célia A. Aveleira
FEFilipe Elvas
Filipe Elvas
António Francisco AmbrósioAntónio Francisco Ambrósio
António Francisco Ambrósio
CCCláudia Cavadas
Cláudia Cavadas
Purpose. Neuropeptide Y (NPY) is one of the most abundant peptides in the central nervous system (CNS), including the retina. This peptide activates various different G-coupled receptors (NPY Y1, Y2, Y4, and Y5) that are also present in the retina. However, the localization of NPY receptors in the several types of retinal cells is not completely known. In this study, we have looked at the distribution of NPY Y1 and Y2 receptors in rat retinal cells to reveal new perspectives on the role of NPY receptors in retina physiology. Methods. Rat retinal neural cell cultures were prepared from newborn Wistar rats (P3–P5) and pure rat Müller cell culture was obtained after treatment of these cells with ascorbic acid. The presence of NPY Y1 and Y2 in retinal cell types was studied by immunocytochemistry. Results. We show that NPY Y1 and Y2 receptors are present on every cell type of rat retinal cell cultures. Neurons, as photoreceptors, bipolar, horizontal, amacrine, and ganglion cells, express these two types of NPY receptors. NPY Y1 and Y2 receptors are also located in macroglial cells (Müller cells and astrocytes) and microglial cells. Conclusions. We have clarified the presence of the NPY Y1 and Y2 receptors in all different cell types that constitute the retina, which we believe will help open new perspectives for studying the physiology and the potential pathophysiologic function of NPY and its receptors in the retina.

4 September 2016 in Toxicology Letters
Verified
Journal Article
Closed access
ACA. Santos Carvalho
A. Santos Carvalho
AFA. Fontes
A. Fontes
NSN. Santos
N. Santos
Ana Margarida AraújoAna Margarida Araújo
Ana Margarida Araújo
PGP. Guedes
P. Guedes
SFS. Ferreira
S. Ferreira